Search Results - Khazaeli, M.B

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Intraperitoneal Pretarget Radioimmunotherapy with CC49 Fusion Protein

    Intraperitoneal Pretarget Radioimmunotherapy with CC49 Fusion Protein by BUCHSBAUM, Donald J, KHAZAELI, M. B, AXWORTHY, Donald B, SCHULTZ, Jody, CHAUDHURI, Tandra R, ZINN, Kurt R, CARPENTER, Mark, LOBUGLIO, Albert F

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Monitoring method for surface contamination caused by selected antineoplastic agents

    Monitoring method for surface contamination caused by selected antineoplastic agents by Larson, RR, Khazaeli, MB, Dillon, HK

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma

    Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma by Chhieng, David C, Rodriguez-Burford, Cristina, Talley, Lynya I, Sviglin, Helena, Stockard, Cecil R, Kleinberg, Marc J, Barnes, Mack N, Partridge, Edward E, Khazaeli, M.B, Grizzle, William E

    Published in Human pathology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N′,N″,N‴-tris(acetic acid)cyclododecane (PA-DOTA)

    Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N′,N″,N‴-tris(acetic acid)cyclododecane (PA-DOTA) by Chappell, Lara L., Rogers, Buck E., Khazaeli, M.B., Mayo, Matthew S., Buchsbaum, Donald J., Brechbiel, Martin W.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Synthesis and Biological Evaluation of Paclitaxel−C225 Conjugate as a Model for Targeted Drug Delivery 1

    Synthesis and Biological Evaluation of Paclitaxel−C225 Conjugate as a Model for Targeted Drug Delivery 1 by Safavy, Ahmad, Bonner, James A., Waksal, Harlan W., Buchsbaum, Donald J., Gillespie, G. Yancey, M.B. Khazaeli, Arani, Ramin, Chen, Dung-Tsa, Carpenter, Mark, Raisch, Kevin P.

    Published in Bioconjugate chemistry
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    503 Phase I radioimmunotherapy (RIT) study of 90Y-CC49 monoclonal antibody (MAb) therapy in patients with advanced non-small cell lung cancer (NSCLC)

    503 Phase I radioimmunotherapy (RIT) study of 90Y-CC49 monoclonal antibody (MAb) therapy in patients with advanced non-small cell lung cancer (NSCLC) by Robert, F., Meredith, R.F., Khazaeli, M.B., Russell, C., Grizzle, W., Newsome, J., Saleh, M., LoBuglio, A.F.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Intraperitoneal Radioimmunotherapy of Ovarian Cancer with177Lu-CC49: A Phase I/II Study

    Intraperitoneal Radioimmunotherapy of Ovarian Cancer with177Lu-CC49: A Phase I/II Study by Alvarez, Ronald D., Partridge, Edward E., Khazaeli, M.B., Plott, Gene, Austin, Max, Kilgore, Larry, Russell, Charles D., Liu, Tiepu, Grizzle, William E., Schlom, Jeffrey, LoBuglio, Albert F., Meredith, Ruby F.

    Published in Gynecologic oncology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomas

    In-111 labeled monoclonal anti-carcinoembryonic antigen antibody (ZCE025) in the immunoscintigraphic imaging of metastatic antigen-producing adenocarcinomas by Saleh, M N, Wheeler, R H, Lee, J Y, Khazaeli, M B, Unger, M W, Russell, C H, LoBuglio, A F

    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Sequential use of indium-111 labeled monoclonal antibodies 96. 5 and ZME-018 does not increase detection sensitivity for metastatic melanoma

    Sequential use of indium-111 labeled monoclonal antibodies 96. 5 and ZME-018 does not increase detection sensitivity for metastatic melanoma by Frontiera, M., Murray, J.L., Lamki, L., Thomas, J., Satterlee, W., Schmelter, R., Rosenblum, M.G., Khazaeli, M.B., Unger, M.W., Robinson, W.A.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: